Back

Heterogeneity in cardiac amyloidosis care across Europe: a key opinion leader survey

30 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: New insights into diagnosis of cardiac amyloidosis Infiltrative Myocardial Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Luuk Kieviet

University Medical Center Utrecht, Utrecht (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Diverse anatomical and metabolic effects of amyloid deposits in transthyretin cardiac amyloidosis revealed by 3D reconstruction of serial block face-scanning electron microscopy images
Doctor S. Saito (Shimotsuke, JP)
Abstract Slides
Presentation thumbnail
Trajectory and prognostic significance of conduction system disease in cardiac transthyretin amyloidosis: a european multicenter cohort study
Doctor L. Schlender (Frankfurt, DE)
Abstract Slides
Presentation thumbnail
Targeted screening for transthyretin cardiac amyloidosis in severe aortic stenosis: development and validation of a clinical risk score
Assistant Professor A. Antonopoulos (Athens, GR)
Abstract Slides
Presentation thumbnail
Prognostic implications of Perugini Grading in a contemporary centre referral cohort undergoing evaluation for suspected cardiac amyloidosis
Ms N. Hartvig Jensen (DK)
Abstract Slides
Presentation thumbnail
Multimodal assessment of disease progression risk among transthyretin amyloid cardiomyopathy patients under disease-modifying therapy
Doctor J. Groeschel (Berlin, DE)
Abstract Slides

Access the full session

Session thumbnail
New insights into diagnosis of cardiac amyloidosis

The Event

Event poster

ESC Congress 2026

30 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Transthyretin amyloid cardiomyopathy: a 2-year single-centre experience
29 August 2022
thumbnail
Congress Session
Cardiac AL amyloidosis: what’s on the horizon for optimised patient care?
26 August 2022
thumbnail
Congress Presentation
A national survey of prevalence and accuracy of echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography - The AC-TIVE Study
1 July 2021
thumbnail
Congress Presentation
Cardiovascular events in patients diagnosed with light chain amyloidosis in the USA: a real-world analysis utilizing electronic health records
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources